[
    "{\"step_by_step_thinking\": \"To determine if ocrelizumab is effective for primary progressive multiple sclerosis, we need to review the available evidence. Ocrelizumab is a medication that targets B cells and is approved for the treatment of relapsing forms of multiple sclerosis. However, its effectiveness for primary progressive multiple sclerosis is uncertain. To find the answer, we can review clinical trials and research studies that have specifically investigated the use of ocrelizumab in primary progressive multiple sclerosis patients.\", \"answer_choice\": \"B. no\"}"
]